HomePMVP • NASDAQ
add
PMV Pharmaceuticals Inc
Previous close
$1.25
Day range
$1.20 - $1.25
Year range
$0.81 - $1.84
Market cap
64.65M USD
Avg Volume
268.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 22.52M | 2.90% |
Net income | -21.06M | -9.53% |
Net profit margin | — | — |
Earnings per share | -0.40 | -8.11% |
EBITDA | -22.49M | -4.53% |
Effective tax rate | 0.03% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 129.25M | -29.31% |
Total assets | 133.84M | -40.11% |
Total liabilities | 12.84M | -49.80% |
Total equity | 121.00M | — |
Shares outstanding | 53.21M | — |
Price to book | 0.55 | — |
Return on assets | -39.28% | — |
Return on capital | -42.73% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -21.06M | -9.53% |
Cash from operations | -19.82M | -17.70% |
Cash from investing | 12.03M | -29.74% |
Cash from financing | 0.00 | — |
Net change in cash | -7.79M | -2,842.96% |
Free cash flow | -12.14M | -22.51% |
About
Founded
2013
Website
Employees
47
